Abstract: A system and method for soliciting a content item, which may include but is not limited to one or more products, services and/or acts, based on an assumption that if a content item can be identified for which a single Internet user has a desire, amongst the millions of world-wide Internet users, there is likely a similar desire among many hundreds or even thousands of Internet users. Even if a content item has not been provided and/or produced, and/or has not been posted to the Internet, the approach assumes that among the millions of Internet users, at least one user has the knowledge and/or skill to produce and/or provide the desired content item, and that by collaboratively grouping relatively nominal sums from a large number of interested Internet users, an individual and/or group of individuals may be sufficiently economically motivated to produce and/or provide and/or post the content item.

Abstract: TGF.beta. is used to increase the numbers of stem cells in a subject's peripheral blood. Then the subject's blood is drawn and the stem cells removed. After myelosuppressive therapy is administered to the subject, the stem cells are administered to the subject. An alternate method provides for TGF.beta. administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed; after a recipient subject receives myelosuppressive therapy, the stem cells are administered to the recipient subject.

Abstract: Methods for modulating the expression of inflammatory cytokines in the central nervous system comprising administering an effective amount of TGF-.beta. are disclosed. The methods include suppressing pro-inflammatory cytokines in the central nervous system by administering an effective amount of TGF-.beta. and inducing anti-inflammatory cytokines in the central nervous system by administering an effective amount of TGF-.beta..

Abstract: Indications associated with dysfunction or malfunction of hematopoiesis or lymphopoiesis are treated with a CIF (TGF-.beta.).

Abstract: This invention includes a method of treating subjects with immunologic and hematologic disorders, such as immune deficiencies and anemias characterized by deficient total hemoglobin. The treatment includes administering to the subject insulin-like growth factor binding protein-3 (IGFBP-3), alone or in a complex including an insulin-like growth factor (IGF), in an amount sufficient to improve the immunologic and/or hematologic disorder, for example, increasing the level of total hemoglobin or improving immune deficiencies, such as occur post-chemotherapy. Another aspect of the invention includes administering IGFBP-3 alone to treat IGF-driven lymphoproliferative conditions, such as leukemias, inflammatory skin diseases, and nasal polyps.

Abstract: TGF.beta. is used to increase the numbers of stem cells in a subject's peripheral blood. Then the subject's blood is drawn and the stem cells removed. After myelosuppressive therapy is administered to the subject, the stem cells are administered to the subject. An alternate method provides for TGF.beta. administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed; after a recipient subject receives myelosuppressive therapy, the stem cells are administered to the recipient subject.

Abstract: Treatment with Transforming Growth Factor-.beta. alone or in combination with a Colony Stimulating Factor therapeutically increases the number of granulocytes and monocyte/macrophages in mammals.